Business Advisory services                  Life Sciences Consulting                  Product Development                  ANDAs                  FTFs                  505 b 2 a                  Late Stage Assets                  Phase-II Trials                  Marketing Authorization’s                  Dossiers                  Site Transfers                  Scale ups                   Tail End Brands                  Technologies and Know-how                  Project Management                   Business Excellence & Six Sigma
Out-licensing strategies are adopted by a number of pharmaceutical, biotechnology, and drug delivery companies in today’s market so as to reap the potential rewards of new technologies, development compounds, and marketed products.
At Garphi, we are the licensing experts. We work with companies to successfully out-licensetechnologies, compounds, and products at all phases of development and product life cycle. We help develop the out-licensing strategy and provide guidance in maximizing the value of the compounds, products, and technologies
The process flow that team Garphi follows is:
  • Develop an effective Information Memorandum
  • Target and contact high-potential licensees
  • Facilitate discussions under confidentiality
  • Obtain feedback from companies contacted
  • Promote competition among interested parties
  • Design appropriate transaction structures
  • Assist with due diligence investigation
  • Negotiate definitive agreements
  • Wanting to Out-license products and technologies….Dial us now at...